Found 11 matching trials
NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
PHASE1A pilot study to evaluate the anti-tumor efficacy of this novel combined re...
Location
University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
PHASE1To evaluate the safety and preliminary efficacy of NP-101 in patients with ...
Location
MD Anderson Cancer Center
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
PHASE3This study will use an open-label design to evaluate the safety of NP101. A...
Location
Multiple Locations
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
PHASE2The goal of this clinical trial is to evaluate the safety, tolerability, an...
Location
L&A Morales Healthcare/ Enrique Villa, MD Principal Investigator
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
PHASE3The primary objective is to evaluate the safety of long-term treatment with...
Location
Multiple Locations
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
PHASE3This study was a randomized, parallel group, double-blind, placebo controll...
Location
Multiple Locations
Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment
PHASE1Surgical resection and liver transplantation are the primary curative treat...
Location
University of Florida
Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults
PHASE1The purpose of this research is to:
1. Compare two study patches having mi...
Location
Prism Research, LLC
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
PHASE1The primary objective is to compare the pharmacokinetics (PK) profiles amon...
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
PHASE1The primary objective is to compare the pharmacokinetics (PK) of NP101 with...
Location
Orlando Clinical Research Center